September 5, 2018 / 5:29 PM / 2 months ago

BUZZ-Correvio Pharma: Climbs as heart drug found safe in EU study

** Canadian drug developer’s U.S.-listed shares climb as much as 16 pct to $5.14 as company reports positive preliminary data of a retrospective study of Brinavess in EU

** Brinavess is CORV’s drug to treat arrhythmia, or an abnormal or irregular heart rhythm

** In August, a 97-patient survey showed 85 pct of patients treated with the drug avoided hospitalization

** In its follow-up safety study, CORV reports on Wednesday that 70.2 pct of the 1,778 patients treated with Brinavess converted to normal heart rhythm in a median time of 11 minutes

** Co reports 28 serious adverse events in the study; no deaths were reported

** More than 380,000 shares traded, 3X their 50-day moving avg

** Inlcuding the day’s gains, CORV had more than tripled YTD (Reporting by Manogna Maddipatla)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below